Across TCGA pan-cancer cohorts, MTND4LP9 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MTND4LP9’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where MTND4LP9 RNA is repressed in tumor relative to normal tissue. In most cancer types MTND4LP9 is over-expressed in tumor, although a few such as THCA and STAD show the opposite, repressed pattern.

THCA, STAD, and BRCA are the cancer types where MTND4LP9 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTND4LP9 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	−0.097	.009	3	view →
STAD	Male	All	−0.185	.023	2	view →
BRCA	All	III,IV	−0.159	.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: MTND4LP9 RNA expression & survival · all MTND4LP9 data types